T1D Exchange Competitors, Revenue and Alternatives

Claim your profile


Boston, MA USA
Total Funding:N/A
Lead Investor(s):N/A
Claim your profile

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • T1D Exchange's estimated annual revenue is currently $20.3M per year.
  • T1D Exchange's estimated revenue per employee is $270,000

Employee Data

  • T1D Exchange has 75 Employees.
  • T1D Exchange grew their employee count by 27% last year.
  • T1D Exchange currently has 8 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
St. Elizabeth's...
Mindleaf Techno...
Cambridge Healt...
AdCare Hospital...
Franklin County...
Boston Software...
Circle Home, In...
Navin, Haffty &...
Missing a competitor? Contribute!?

T1D Exchange is a nonprofit research organization dedicated to accelerating therapies and improving care for people affected by type 1 diabetes. T1D Exchange actively supports discovery and innovationparticularly at its earliest stages. At the same time, the organization understands that laboratory breakthroughs are not enough. Evidence gathered in the real world is necessary to help bridge the gap between discovery in research settings and impact in people's lives. The T1D Exchange model uses cutting-edge research tools, methods and programs to gather evidence from the real-world and clinical experiences of people living with type 1 diabetes. Visit our online community for people with type 1 diabetes at myglu.org. Follow us on Twitter: - @t1dexchange Follow us on Facebook: - http://www.facebook.com/myglu

keywords:Biotechnology,Healthcare,Healthcare Providers,Pharmaceuticals


Number of Employees


Revenue (est)


Current Jobs


Employee Growth %


Total Funding







Executive Contacts

Daniel PereiraEditorial & Communications ManagerEmail Available
Anna Floreen SabinoEducation And Outreach Manager
Raymond BurgettCreative Design ManagerEmail Available
Kara Jean PageBiobank Project ManagerEmail Available
Rupa Laxmi ShahAssociate Director Of Development And Corporate Partnerships
Maureen O'NeilExecutive Assistant To Chief Executive Officer
Alicia McAuliffe-FogartyVice President
Sara LandryDirector of Human ResourcesEmail Available
Rebecca ParkesChief Operating OfficerEmail Available
Wendy WolfVP, RegistryEmail Available

T1D Exchange News

08/14/2019 - Type 1 Diabetes Often Misdiagnosed in Adults and Children

Results of a survey of 2526 participants recruited from the T1D Exchange clinic and online communities were published in the July 2019 issue ...

08/14/2019 - Type 1 Diabetes Misdiagnosed in One-Fourth of Children, Adults

Cynthia Munoz, Ph.D., from the University of Southern California in Los Angeles, and colleagues used data from the T1D Exchange clinic ...

08/16/2019 - Medtronic receives FDA investigational approval for testing of ...

... with that of standard devices in 150 adults with type 1 diabetes aged ... Medtronic, Merck, NIDDK, Novo Nordisk, Sanofi and T1D Exchange.

T1D Exchange Executive Hires

2012-12-07Dana BallCEOArticle
2017-08-16Alicia McAuliffe-FogartyVP Patient ResearchArticle